QlikTech Customer Astellas Pharma Named Ventana Research 2013 Leadership Award Winner

  QlikTech Customer Astellas Pharma Named Ventana Research 2013 Leadership
  Award Winner

    Astellas recognized for superior results while leveraging the QlikView
                         Business Discovery solution

Business Wire

RADNOR, Pa. -- April 30, 2013

QlikTech, (NASDAQ: QLIK) a leader in Business Discovery – user-driven Business
Intelligence (BI), today announced that Astellas Pharma US, Inc., a QlikTech
customer, was named a Ventana Research 2013 Leadership Award Winner for
Business Intelligence. Through successful implementation of QlikView, as well
as effectively leveraging people, processes, and information to achieve
superior results, Astellas was named the leader in the business intelligence
category.The winner selected in this category has demonstrated exemplary
application of business intelligence to help its organization improve
decision-making and overall performance.

Astellas Pharma is one of the world’s largest pharmaceutical companies. The
company works toward improving the health of people around the world through
innovative and reliable pharmaceutical products. It is this focus on
leadership and innovation that led Astellas to take on a new business
intelligence and analytics initiative in 2012, selecting QlikView to reduce
the number of ad hoc data pulls from the IT department, bring together
disparate reports, and quickly create charts and graphs to share with the
leadership team it supports.

Since deploying QlikView, Astellas and its sales analytics team have been able
to provide actionable insights from the data the company collects. The team
has been able to maximize information while minimizing the time spent finding
it. Additionally, using new insights enabled by QlikView, Astellas’ sales
leadership team has been able to continue growing market share, realign the
sales force to be more effective, and support the successful launch of a new
product, all resulting in a 4 percent increase in sales in the related brands.

“We’re very excited about the work Astellas has been able to accomplish using
QlikView,” said Ellen Derrico, Director Global Market Development, Life
Sciences & Healthcare at QlikTech. “The company has deployed QlikView to over
100 people – including the CEO – demonstrating that it is truly a business
discovery solution for everyone that enables informed decision-making at every
level of an organization.”

The Ventana Research Leadership Awards, now in their eighth year, recognize
organizations and supporting technology vendors that have effectively achieved
superior results through using people, processes, information and technology
while applying best practices within specific business and technology
categories. The awards distinguish pioneers and leaders -- both organizations
and individuals that exemplify clear visionary and transformative leadership.
The award recipients have demonstrated an understanding that the successful
management of their processes and performance requiring a heightened level of
expertise, determination and a team effort. The awards will be presented at
the Ventana Research Business Technology Leadership Summit on May 29th and
30th, 2013 at the Hyatt Fisherman's Wharf in San Francisco, CA.

For more information about the Ventana Research Awards, and to view the full
list of winners, please visit:

About Astellas Pharma, Inc.

Astellas is a recognized leader in transplantation and has been committed to
the field of immunology for more than 20 years. Dedicated to supporting the
advancement of care for patients, Astellas continues to build upon its legacy
and leadership in transplantation by investing in ongoing clinical research
and new product development.

Astellas Pharma US, Inc., located in Northbrook, Illinois, is a US affiliate
of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceutical products. The organization
is committed to becoming a global category leader in focused areas by
combining outstanding R&D and marketing capabilities. For more information
about Astellas Pharma US, Inc., please visit our website atwww.Astellas.us.

About QlikTech

QlikTech (NASDAQ: QLIK) is a leader in Business Discovery—user-driven Business
Intelligence (BI). Its QlikView Business Discovery solution bridges the gap
between traditional BI solutions and inadequate spreadsheet applications. The
in-memory associative search technology QlikTech pioneered created the
self-service BI category, allowing users to explore information freely rather
than being confined to a predefined path of questions. Appropriate from SMB to
the largest global enterprise, QlikView’s self-service analysis can be
deployed with data governance in days or weeks. The QlikView Business
Discovery platform’s app-driven model works with existing BI solutions,
offering an immersive mobile and social, collaborative experience.
Headquartered in Radnor, Pennsylvania, QlikTech has offices around the world
serving approximately 28,000 customers in over 100 countries.

Qlik™, QlikView™, QlikTech™, and the QlikTech logo are trademarks of QlikTech
International AB which have been registered in multiple countries. Other marks
and logos mentioned are the trademarks of their respective owners.


Media Contact:
For QlikTech
Amanda Keane, 617-520-7260
Press spacebar to pause and continue. Press esc to stop.